XML 78 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurements Level 3 (Tables)
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Assets and (liabilities) carried at fair value by hierarchy level
Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of June 30, 2017
 
Total
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
Asset-backed-securities ("ABS")
$
2,354

$

$
2,258

$
96

Collateralized debt obligations ("CDOs")
2,457


2,118

339

Commercial mortgage-backed securities ("CMBS")
5,173


5,075

98

Corporate
26,044


24,908

1,136

Foreign government/government agencies
1,297


1,268

29

Bonds of municipalities and political subdivisions ("municipal bonds")
12,284


12,198

86

Residential mortgage-backed securities ("RMBS")
4,219


2,208

2,011

U.S. Treasuries
4,006

463

3,543


Total fixed maturities
57,834

463

53,576

3,795

Fixed maturities, FVO
146


146


Equity securities, trading [1]
11

11



Equity securities, AFS
1,055

789

168

98

Derivative assets
 
 
 
 
Credit derivatives
8


8


Equity derivatives
2


1

1

Interest rate derivatives
2


2


GMWB hedging instruments
45



45

Macro hedge program
94


8

86

Total derivative assets [2]
151


19

132

Short-term investments
4,716

1,916

2,800


Reinsurance recoverable for GMWB
57



57

Modified coinsurance reinsurance contracts
58


58


Separate account assets [3]
112,559

73,019

38,466

192

Total assets accounted for at fair value on a recurring basis
$
176,587

$
76,198

$
95,233

$
4,274

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
GMWB embedded derivative
$
(134
)
$

$

$
(134
)
Equity linked notes
(37
)


(37
)
Total other policyholder funds and benefits payable
(171
)


(171
)
Derivative liabilities
 
 
 
 
Credit derivatives
(6
)

(6
)

Equity derivatives
38


37

1

Foreign exchange derivatives
(267
)

(267
)

Interest rate derivatives
(488
)

(462
)
(26
)
GMWB hedging instruments
40


45

(5
)
Macro hedge program
74



74

Total derivative liabilities [4]
(609
)

(653
)
44

Contingent consideration [5]
(27
)


(27
)
Total liabilities accounted for at fair value on a recurring basis
$
(807
)
$

$
(653
)
$
(154
)

Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of December 31, 2016
 
Total
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
2,382

$

$
2,300

$
82

CDOs
1,916


1,502

414

CMBS
4,936


4,856

80

Corporate
25,666


24,586

1,080

Foreign government/government agencies
1,171


1,107

64

Municipal bonds
11,486


11,368

118

RMBS
4,767


2,795

1,972

U.S. Treasuries
3,679

620

3,059


Total fixed maturities
56,003

620

51,573

3,810

Fixed maturities, FVO
293

1

281

11

Equity securities, trading [1]
11

11



Equity securities, AFS
1,097

821

177

99

Derivative assets
 
 
 
 
Credit derivatives
17


17


Foreign exchange derivatives
27


27


Interest rate derivatives
(427
)

(427
)

GMWB hedging instruments
74


14

60

Macro hedge program
128


8

120

Other derivative contracts
1



1

Total derivative assets [2]
(180
)

(361
)
181

Short-term investments
3,244

878

2,366


Reinsurance recoverable for GMWB
73



73

Modified coinsurance reinsurance contracts
68


68


Separate account assets [3]
111,634

71,606

38,856

201

Total assets accounted for at fair value on a recurring basis
$
172,243

$
73,937

$
92,960

$
4,375

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
GMWB embedded derivative
$
(241
)
$

$

$
(241
)
Equity linked notes
(33
)


(33
)
Total other policyholder funds and benefits payable
(274
)


(274
)
Derivative liabilities
 
 
 
 
Credit derivatives
(13
)

(13
)

Equity derivatives
33


33


Foreign exchange derivatives
(237
)

(237
)

Interest rate derivatives
(542
)

(521
)
(21
)
GMWB hedging instruments
20


(1
)
21

Macro hedge program
50


3

47

Total derivative liabilities [4]
(689
)

(736
)
47

Contingent consideration [5]
(25
)


(25
)
Total liabilities accounted for at fair value on a recurring basis
$
(988
)
$

$
(736
)
$
(252
)
[1]
Included in other investments on the Condensed Consolidated Balance Sheets.
[2]
Includes OTC and OTC-cleared derivative instruments in a net positive fair value position after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. See footnote 4 to this table for derivative liabilities.
[3]
Approximately $4.2 billion and $4.0 billion of investment sales receivable, as of June 30, 2017, and December 31, 2016, respectively, are excluded from this disclosure requirement because they are trade receivables in the ordinary course of business where the carrying amount approximates fair value. Included in the total fair value amount are $882 and $1.0 billion of investments, as of June 30, 2017 and December 31, 2016, for which the fair value is estimated using the net asset value per unit as a practical expedient which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy.
[4]
Includes OTC and OTC-cleared derivative instruments in a net negative fair value position (derivative liability) after consideration of the accrued interest and impact of collateral posting requirements, which may be imposed by agreements, clearing house rules and applicable law.
[5]
For additional information see the Contingent Consideration section below.
Information about significant unobservable inputs used in Level 3 assets measured at fair value
Significant Unobservable Inputs for Level 3 - Freestanding Derivatives
 
Fair
Value
Predominant
Valuation 
Technique
Significant Unobservable Input
Minimum
Maximum
Impact of 
Increase in Input on 
Fair Value [1]
As of June 30, 2017
Interest rate derivatives
 
 
 
 
 
 
Interest rate swaps
$
(29
)
Discounted cash flows
Swap curve beyond 30 years
3
%
3
%
Decrease
Interest rate swaptions [2]
3

Option model
Interest rate volatility
2
%
2
%
Increase
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
(39
)
Option model
Equity volatility
16
%
20
%
Increase
Equity options
6

Option model
Equity volatility
26
%
28
%
Increase
Customized swaps
73

Discounted cash flows
Equity volatility
9
%
30
%
Increase
Macro hedge program [3]
 
 
 
 
 
 
Equity options
171

Option model
Equity volatility
15
%
26
%
Increase
As of December 31, 2016
Interest rate derivatives
 
 
 
 
 
 
Interest rate swaps
$
(29
)
Discounted cash flows
Swap curve beyond 30 years
3
%
3
%
Decrease
Interest rate swaptions [2]
8

Option model
Interest rate volatility
2
%
2
%
Increase
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
(36
)
Option model
Equity volatility
20
%
23
%
Increase
Equity options
17

Option model
Equity volatility
27
%
30
%
Increase
Customized swaps
100

Discounted cash flows
Equity volatility
12
%
30
%
Increase
Macro hedge program [3]
 
 
 
 
 
 
Equity options
188

Option model
Equity volatility
17
%
28
%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. Changes are based on long positions, unless otherwise noted. Changes in fair value will be inversely impacted for short positions.
[2]
The swaptions presented are purchased options that have the right to enter into a pay-fixed swap.
[3]
Excludes derivatives for which the Company bases fair value on broker quotations
Significant Unobservable Inputs for Level 3 - Securities
Assets accounted for at fair value on a recurring basis
Fair
Value
Predominant
Valuation
Technique
Significant
Unobservable Input
Minimum
Maximum
Weighted Average [1]
Impact of
Increase in Input
on Fair Value [2]
As of June 30, 2017
CMBS [3]
$
51

Discounted cash flows
Spread (encompasses prepayment, default risk and loss severity)
9 bps
1,816 bps
466 bps
Decrease
Corporate [4]
489

Discounted cash flows
Spread
108 bps
944 bps
303 bps
Decrease
Municipal [3]
70

Discounted cash flows
Spread
166 bps
222 bps
183 bps
Decrease
RMBS [3]
2,002

Discounted cash flows
Spread
40 bps
624 bps
126 bps
Decrease
 
 
 
Constant prepayment rate
—%
14%
5%
 Decrease [5]
 
 
 
Constant default rate
2%
10%
5%
Decrease
 
 
 
Loss severity
—%
100%
71%
Decrease
As of December 31, 2016
CMBS [3]
$
52

Discounted cash flows
Spread (encompasses prepayment, default risk and loss severity)
10 bps
1,273 bps
366 bps
Decrease
Corporate [4]
510

Discounted cash flows
Spread
122 bps
1,302 bps
359 bps
Decrease
Municipal [3]
101

Discounted cash flows
Spread
135 bps
286 bps
221 bps
Decrease
RMBS [3]
1,963

Discounted cash flows
Spread
16 bps
1,830 bps
192 bps
Decrease
 
 
 
Constant prepayment rate
—%
20%
4%
Decrease [5]
 
 
 
Constant default rate
—%
11%
5%
Decrease
 
 
 
Loss severity
—%
100%
75%
Decrease
[1]
The weighted average is determined based on the fair value of the securities.
[2]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[3]
Excludes securities for which the Company based fair value on broker quotations.
[4]
Excludes securities for which the Company bases fair value on broker quotations; however, included are broker priced lower-rated private placement securities for which the Company receives spread and yield information to corroborate the fair value.
[5]
Decrease for above market rate coupons and increase for below market rate coupons.
Significant Unobservable Inputs for Level 3 GMWB Embedded Customized and Reinsurance Derivatives
As of June 30, 2017
Significant Unobservable Input
Unobservable Inputs (Minimum)
Unobservable Inputs (Maximum)
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
15%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
40%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
9%
30%
Increase
As of December 31, 2016
Significant Unobservable Input
Unobservable Inputs (Minimum)
Unobservable Inputs (Maximum)
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
15%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
40%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
12%
30%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[2]
Range represents assumed cumulative percentages of policyholders taking withdrawals.
[3]
Range represents assumed cumulative annual amount withdrawn by policyholders.
[4]
Range represents assumed annual percentages of full surrender of the underlying variable annuity contracts across all policy durations for in force business.
[5]
Range represents assumed cumulative percentages of policyholders that would elect to reset their guaranteed benefit base.
[6]
Range represents implied market volatilities for equity indices based on multiple pricing sources.
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
The Company uses derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instrument may not be classified with the same fair value hierarchy level as the associated asset or liability. Therefore, the realized and unrealized gains and losses on derivatives reported in the Level 3 roll-forward may be offset by realized and unrealized gains and losses of the associated assets and liabilities in other line items of the financial statements.
Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Three Months Ended June 30, 2017
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of March 31, 2017
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases [8]
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of June 30, 2017
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
125

$

$

$
25

$
(1
)
$

$

$
(53
)
$
96

 
CDOs
319


(5
)
300

(207
)


(68
)
339

 
CMBS
117


1

19

(3
)


(36
)
98

 
Corporate
1,078

(12
)
14

46

(4
)
(30
)
52

(8
)
1,136

 
Foreign Govt./Govt. Agencies
66



6

(1
)
(2
)

(40
)
29

 
Municipal
117

4

(1
)


(34
)


86

 
RMBS
2,048


27

50

(114
)



2,011

Total Fixed Maturities, AFS
3,870

(8
)
36

446

(330
)
(66
)
52

(205
)
3,795

Equity Securities, AFS
99


(1
)





98

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity
4

(2
)






2

 
Interest rate
(24
)
(2
)






(26
)
 
GMWB hedging instruments
46

(6
)






40

 
Macro hedge program
159

1







160

 
Other contracts









Total Freestanding Derivatives, net [5]
185

(9
)






176

Reinsurance Recoverable for GMWB
60

(7
)


4




57

Separate Accounts
277

2


13

(2
)
(34
)
7

(71
)
192

Total Assets
$
4,491

$
(22
)
$
35

$
459

$
(328
)
$
(100
)
$
59

$
(276
)
$
4,318

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(157
)
$
40

$

$

$
(17
)
$

$

$

$
(134
)
 
Equity Linked Notes
(36
)
(1
)






(37
)
Total Other Policyholder Funds and Benefits Payable
(193
)
39



(17
)



(171
)
Contingent Consideration [7]
(26
)
(1
)






(27
)
Total Liabilities
$
(219
)
$
38

$

$

$
(17
)
$

$

$

$
(198
)
Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Six Months Ended June 30, 2017
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of January 1, 2017
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases [8]
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of June 30, 2017
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
82

$

$

$
70

$
(6
)
$

$
26

$
(76
)
$
96

 
CDOs
414


(1
)
300

(208
)


(166
)
339

 
CMBS
80

(1
)
1

75

(6
)


(51
)
98

 
Corporate
1,080

(6
)
30

215

(40
)
(190
)
92

(45
)
1,136

 
Foreign Govt./Govt. Agencies
64


3

6

(2
)
(2
)

(40
)
29

 
Municipal
118

4

4



(40
)


86

 
RMBS
1,972


33

223

(210
)
(7
)


2,011

Total Fixed Maturities, AFS
3,810

(3
)
70

889

(472
)
(239
)
118

(378
)
3,795

Fixed Maturities, FVO
11



4

(2
)
(13
)



Equity Securities, AFS
99


(5
)
4





98

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity

(3
)

5





2

 
Interest rate
(21
)
(5
)






(26
)
 
GMWB hedging instruments
81

(41
)






40

 
Macro hedge program
167

(7
)






160

 
Other contracts
1

(1
)







Total Freestanding Derivatives, net [5]
228

(57
)

5





176

Reinsurance Recoverable for GMWB
73

(23
)


7




57

Separate Accounts
201

3

2

111

(7
)
(42
)
10

(86
)
192

Total Assets
$
4,422

$
(80
)
$
67

$
1,013

$
(474
)
$
(294
)
$
128

$
(464
)
$
4,318

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(241
)
$
140

$

$

$
(33
)
$

$

$

$
(134
)
 
Equity Linked Notes
(33
)
(4
)






(37
)
Total Other Policyholder Funds and Benefits Payable
(274
)
136



(33
)



(171
)
Contingent Consideration [7]
(25
)
(2
)






(27
)
Total Liabilities
$
(299
)
$
134

$

$

$
(33
)
$

$

$

$
(198
)

Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Three Months Ended June 30, 2016
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of March 31, 2016
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases [8]
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of June 30, 2016
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
32

$

$

$

$
(4
)
$

$
13

$

$
41

 
CDOs
542

(1
)
(2
)

(61
)



478

 
CMBS
134


5

10

(9
)
(3
)
1

(59
)
79

 
Corporate
834

(1
)
19

37

(50
)
(66
)
455

(92
)
1,136

 
Foreign Govt./Govt. Agencies
76

1

4

1

(1
)
(9
)


72

 
Municipal
50


4

20



16


90

 
RMBS
1,886


10

97

(101
)

3

(22
)
1,873

Total Fixed Maturities, AFS
3,554

(1
)
40

165

(226
)
(78
)
488

(173
)
3,769

Fixed Maturities, FVO
14

1


1

(1
)
(3
)

(6
)
6

Equity Securities, AFS
92

1

5

2


(3
)


97

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity
5

(4
)






1

 
Interest rate
(28
)
(4
)






(32
)
 
GMWB hedging instruments
144

15






6

165

 
Macro hedge program
145

(4
)






141

 
Other contracts
5

(1
)






4

Total Freestanding Derivatives, net [5]
271

2






6

279

Reinsurance Recoverable for GMWB
99

3



4




106

Separate Accounts
154


3

22

(3
)
(6
)
3

(2
)
171

Total Assets
$
4,184

$
6

$
48

$
190

$
(226
)
$
(90
)
$
491

$
(175
)
$
4,428

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(361
)
$
(35
)
$

$

$
(16
)
$

$

$

$
(412
)
 
Equity Linked Notes
(25
)
(3
)






(28
)
Total Other Policyholder Funds and Benefits Payable
(386
)
(38
)


(16
)



(440
)
Total Liabilities
$
(386
)
$
(38
)
$

$

$
(16
)
$

$

$

$
(440
)

Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Six Months Ended June 30, 2016
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of January 1, 2016
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases [8]
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of June 30, 2016
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
37

$

$

$

$
(7
)
$

$
18

$
(7
)
$
41

 
CDOs
541

(1
)
(2
)

(60
)



478

 
CMBS
150

(1
)
(3
)
50

(18
)
(3
)
1

(97
)
79

 
Corporate
854

(14
)
12

67

(55
)
(91
)
513

(150
)
1,136

 
Foreign Govt./Govt. Agencies
60

1

9

15

(2
)
(11
)


72

 
Municipal
49


5

20



16


90

 
RMBS
1,622


(4
)
430

(158
)

5

(22
)
1,873

Total Fixed Maturities, AFS
3,313

(15
)
17

582

(300
)
(105
)
553

(276
)
3,769

Fixed Maturities, FVO
16

(1
)

6

(2
)
(3
)

(10
)
6

Equity Securities, AFS
93


7

2


(5
)


97

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity

(15
)

16





1

 
Interest rate
(22
)
(10
)






(32
)
 
GMWB hedging instruments
135

24






6

165

 
Macro hedge program
147

(4
)


(2
)



141

 
Other contracts
7

(3
)






4

Total Freestanding Derivatives, net [5]
267

(8
)

16

(2
)


6

279

Reinsurance Recoverable for GMWB
83

16



7




106

Separate Accounts
139


7

61

(9
)
(16
)
6

(17
)
171

Total Assets
$
3,911

$
(8
)
$
31

$
667

$
(306
)
$
(129
)
$
559

$
(297
)
$
4,428

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(262
)
$
(117
)
$

$

$
(33
)
$

$

$

$
(412
)
 
Equity Linked Notes
(26
)
(2
)






(28
)
Total Other Policyholder Funds and Benefits Payable
(288
)
(119
)


(33
)



(440
)
Total Liabilities
$
(288
)
$
(119
)
$

$

$
(33
)
$

$

$

$
(440
)
[1]
The Company classifies realized and unrealized gains (losses) on GMWB reinsurance derivatives and GMWB embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives.
[2]
Amounts in these rows are generally reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[3]
All amounts are before income taxes and amortization of DAC.
[4]
Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs.
[5]
Derivative instruments are reported in this table on a net basis for asset (liability) positions and reported in the Condensed Consolidated Balance Sheets in other investments and other liabilities.
[6]
Includes both market and non-market impacts in deriving realized and unrealized gains (losses).
[7]
For additional information, see the Contingent Consideration section of Note 5 - Fair Value Measurements of Notes to Condensed Consolidated Financial Statements.
[8]
Includes issuance of contingent consideration associated with the Lattice acquisition, see Note 2 - Business Disposition of Notes to Condensed Consolidated Financial Statements for additional discussion.
Changes in Unrealized Gains (Losses) Included in Net Income for Financial Instruments Classified as Level 3 Still Held at End of Period
 
 
Three months ended June 30,
Six months ended June 30,
 
 
2017 [1] [2]
2016 [1] [2]
2017 [1] [2]
2016 [1] [2]
Assets
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
CMBS
$

$

$
(1
)
$
(1
)
 
Corporate
(12
)
(1
)
(12
)
(1
)
Total Fixed Maturities, AFS
(12
)
(1
)
(13
)
(2
)
Fixed Maturities, FVO



(1
)
Freestanding Derivatives, net
 
 
 
 
 
Equity
(2
)
(4
)
(2
)
(15
)
 
Interest rate
(2
)
(4
)
(2
)
(10
)
 
GMWB hedging instruments
(6
)
15

(42
)
24

 
Macro hedge program
2

(4
)
(6
)
(4
)
 
Other Contracts

(1
)

(3
)
Total Freestanding Derivatives, net
(8
)
2

(52
)
(8
)
Reinsurance Recoverable for GMWB
(7
)
3

(23
)
16

Separate Accounts


1


Total Assets
$
(27
)
$
4

$
(87
)
$
5

Liabilities
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
40

$
(35
)
$
140

$
(117
)
 
Equity Linked Notes
(1
)
(3
)
(4
)
(2
)
Total Other Policyholder Funds and Benefits Payable
39

(38
)
136

(119
)
Contingent Consideration [3]
(1
)

(2
)

Total Liabilities
$
38

$
(38
)
$
134

$
(119
)
[1]
All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[2]
Amounts presented are for Level 3 only and therefore may not agree to other disclosures included herein.
[3]
For additional information, see the Contingent Consideration section of Note 5 - Fair Value Measurements of Notes to Condensed Consolidated Financial Statements.
Fair value of assets and liabilities accounted for using the fair value option
Changes in Fair Value of Assets using Fair Value Option
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
2016
 
2017
2016
Assets
 
 
 
 
 
Fixed maturities, FVO
 
 
 
 
 
Corporate
$

$

 
$
(1
)
$

Foreign government


 

(1
)
RMBS

4

 
1

5

Total fixed maturities, FVO
$

$
4

 
$

$
4

Equity, FVO
3


 
2

(34
)
Total realized capital gains (losses)
$
3

$
4

 
$
2

$
(30
)
Fair value of assets and liabilities accounted for using the fair value option
Fair Value of Assets and Liabilities using the Fair Value Option
 
June 30, 2017
December 31, 2016
Assets
 
 
Fixed maturities, FVO
 
 
ABS
$

$
7

CDOs

3

CMBS

8

Corporate

40

U.S government

7

RMBS
146

228

Total fixed maturities, FVO
$
146

$
293



Financial Instruments Not Carried at Fair Value
Financial Assets and Liabilities Not Carried at Fair Value
 
Fair Value Hierarchy Level
Carrying Amount
Fair Value
June 30, 2017
Assets
 
 
 
Policy loans
Level 3
$
1,433

$
1,433

Mortgage loans
Level 3
5,796

5,871

Liabilities
 
 
 
Other policyholder funds and benefits payable [1]
Level 3
$
6,403

$
6,603

Senior notes [2]
Level 2
3,555

4,200

Junior subordinated debentures [2]
Level 2
1,582

1,756

Consumer notes [3] [4]
Level 3
10

10

Assumed investment contracts [3]
Level 3
514

541

December 31, 2016
Assets
 
 
 
Policy loans
Level 3
$
1,444

$
1,444

Mortgage loans
Level 3
5,697

5,721

Liabilities
 
 
 
Other policyholder funds and benefits payable [1]
Level 3
$
6,714

$
6,906

Senior notes [2]
Level 2
3,969

4,487

Junior subordinated debentures [2]
Level 2
1,083

1,246

Consumer notes [3] [4]
Level 3
20

20

Assumed investment contracts [3]
Level 3
487

526

[1]
Excludes guarantees on variable annuities, group accident and health and universal life insurance contracts, including corporate owned life insurance.
[2]
Included in long-term debt in the Condensed Consolidated Balance Sheets, except for current maturities, which are included in short-term debt.
[3]
Excludes amounts carried at fair value and included in preceding disclosures.
[4]
Included in other liabilities in the Condensed Consolidated Balance Sheets.